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Characterization of Induced 
Pluripotent Stem Cell Microvesicle 
Genesis, Morphology and 
Pluripotent Content
Jing Zhou1,2,*, Shima Ghoroghi1,*, Alberto Benito-Martin3, Hao Wu1,2, 
Uchenna John Unachukwu1,4, Linda Saxe Einbond1, Sara Guariglia5, Hector Peinado3,6  
& Stephen Redenti1,2
Microvesicles (MVs) are lipid bilayer-covered cell fragments that range in diameter from 30 nm–1uM 
and are released from all cell types. An increasing number of studies reveal that MVs contain microRNA, 
mRNA and protein that can be detected in the extracellular space. In this study, we characterized 
induced pluripotent stem cell (iPSC) MV genesis, content and fusion to retinal progenitor cells (RPCs)  
in vitro. Nanoparticle tracking revealed that iPSCs released approximately 2200 MVs cell/hour in the 
first 12 hrs with an average diameter of 122 nm. Electron and light microscopic analysis of iPSCs showed 
MV release via lipid bilayer budding. The mRNA content of iPSC MVs was characterized and revealed 
the presence of the transcription factors Oct-3/4, Nanog, Klf4, and C-Myc. The protein content of iPSCs 
MVs, detected by immunogold electron microscopy, revealed the presence of the Oct-3/4 and Nanog. 
Isolated iPSC MVs were shown to fuse with RPCs in vitro at multiple points along the plasma membrane. 
These findings demonstrate that the mRNA and protein cargo in iPSC MVs have established roles in 
maintenance of pluripotency. Building on this work, iPSC derived MVs may be shown to be involved in 
maintaining cellular pluripotency and may have application in regenerative strategies for neural tissue.
The release and fusion activity of microvesicles (MVs) have been analyzed from a number of cell types, including 
tumor cells, embryonic stem cells, neural and epithelial cells1–5 and have been isolated from bodily fluids includ-
ing cerebral spinal fluid, blood and urine6,7. MVs can be categorized based on size, site of origin and mechanism 
of formation as either microparticles (100 nm–1 um) or exosomes (30–100 nm)8–10. While microparticles bud 
directly from the plasma membrane, exosomes are formed by inward budding of endosomal membranes, intra-
cellular multivesicular body formation, plasma membrane fusion and exocytotic release10–13. Following release, 
MVs can circulate locally in the extracellular space adjacent to the cell of origin, or move some distance by 
diffusion in biological fluids9,14. Both microparticles and exosomes released into the extracellular environment 
generate a heterogeneous population containing a range of genetic information15,16. Although the significance of 
microvesicle genesis and transfer remains largely undefined, a growing number of studies predict that MV signa-
ling represents a novel mechanism of bi-directional genetic transfer and communication17–19.
Microvesicles have unique molecular compositions derived from the type and activation state of the cell of 
origin and have been shown to contain cell specific subsets of proteins, mRNA, microRNA and organelles20,21. 
Embryonic stem cell (ES) derived MVs have been shown to contain ES specific mRNA with the potential to influ-
ence target hematopoetic progenitor cell gene expression. Hematopoietic progenitor cells co-cultured with ES 
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derived MVs exhibited enhanced survival and upregulated expression of pluripotent genes22,23. Also, MVs from 
adult human bone marrow and mesenchymal stem cells were shown to horizontally transfer mRNAs to recipient 
kidney tubular cells, contributing resistance to apoptosis and repair of acute kidney injury24. Similarly, MVs from 
human liver stem cells were shown to accelerate the morphological and functional recovery of liver tissue in a rat 
hepatectomy model25.
In this study, mouse iPSC derived MVs were characterized for cell surface release, morphology and molecular 
composition. We demonstrate that iPSC derived MVs contain a group of iPSC-specific pluripotent transcription 
factors. We also evaluated iPSC-derived MVs release rate and fusion to target cells in vitro. Results from this 
study suggest that iPSC derived MVs are vehicles for transfer of pluripotent genetic material to target cells with 
potential application toward regenerative strategies in neural tissue. Analysis of iPSC-derived MVs may enhance 
understanding of disease pathogenesis and be useful in developing personalized medicine.
Materials and Methods
Cell culture. All cells were cultured under sterile conditions and maintained in a 95% O2/5% CO2 humid-
ified incubator at 37 °C. Primary mouse Nanog-GFP iPSCs were purchased from Stemgent (Cambridge, MA, 
USA) and cultured in Knockout DMEM (GIBCO, Invitrogen), supplemented with 15% fetal bovine serum (FBS; 
Sigma), 2 mM L-glutamine, 0.1 mM nonessential amino acids, 0.1 mM β -mercaptoethanol, 5 mg/ml penicil-
lin/100 mg/ml streptomycin, and leukemia inhibitory factor (1 × 107 U/ml). The iPSCs used for MV analysis were 
plated and cultured without MEFs on 0.1% gelatin-coated T75 culture flasks. Actin promoter-GFP mouse RPCs 
were isolated from post-natal day one mice and cultured as previously described26.
Cell membrane labeling. To visualize lipid membranes, iPSCs were labeled with the TRITC fluorescent 
lipophilic dye PKH26 (Sigma). iPSCs (2 × 107 cells) were suspended in PKH26 dilutent-C and mixed with 
4 × 10−6 M PKH26 dye and incubated at 25 °C for 5 min. The staining reaction was quenched by addition of an 
equal volume of DMEM supplemented with 1% BSA. Labeled iPSCs were then centrifuged, and re-suspended in 
pre-warmed media for further analysis.
Isolation of microvesicles. Microvesicles were isolated using a modified protocol based on previous work 
by Yuan et al.8. Exosomes in FBS were depleted by first centrifuging FBS at 110,000 × g for 70 min and then filter-
ing using a 0.2 μ m pore size filter. To collect iPSC MVs, cells were cultured from 24–48 h, and conditioned media 
was collected and transferred to centrifuge tubes (polypropylene conical bottom) and centrifuged at 500 × g for 
10 min to pellet cells at room temperature; supernatant was collected and centrifuged at 10,000 × g for 20 min at 
4 °C (Beckman Ultracentrifuge, Rotor 60ti) to remove cell fragments and debris; final supernatant was spun at 
100, 000 × g for 70 min at 4 °C to pellet the microvesicles. Microvesicles were resuspended in phosphate-buffered 
saline (PBS) and stored at − 80 °C for further analysis.
NanoSight analysis of microvesicle size and concentration. Microvesicle size and number were 
assessed with NanoSight NS500 system. From 12–48 h after culture in T-75 flasks, conditional media was col-
lected and transferred to centrifuge tubes. Collection of supernatant was identical to previously described isola-
tion of microvesicles, except supernatant before 100, 000 × g ultracentrifugation was used for NanoSight analysis. 
Control media, non-conditioned, was processed at the same time. Final supernatant was diluted at 1:20 in PBS 
and 1ml was used for NanoSight analysis. The NanoSight system uses a laser light source to illuminate nano-scale 
particles, detected individually as light-scattered points moving via Brownian motion. Polydispersity was quan-
tified, and we used Nanoparticle Tracking Analysis (NTA) software 2.3 to track and size nanoparticles on an 
individual basis. Results are displayed as a frequency sized distribution graph describing the number of particles 
per ml. The concentration of released MVs was calculated to determine average number of MVs with standard 
deviation in conditioned medium at 12 h, 24 h and 48 h reported and compared using a Student’s t-test.
Preparation of PKH26-labelled iPSC samples for confocal microscopy. After labeling iPSCs with 
fluorescent PKH26, cells were incubated at 37 °C for 3 h on glass cover slips. iPSCs were then fixed on coverslips 
with 4% PFA for 5 min and washed with PBS 3 times at 10 min intervals. The samples were imaged at 40xusing a 
Leica SP2 AOBS confocal microscope. Excitation was achieved using a HeNe laser. The excitation wavelength was 
543 nm and the emission range was 553–650 nm. Z-stacks were obtained and a 3-dimensional reconstruction was 
done using Nikon Elements software.
Transmission electron microscopy (TEM). Cultured iPSCs (4 × 107 cells) were fixed in 2.5% glutar-
aldehyde with 4% paraformaldehyde for 2.5 h and washed in PBS for 2–4 h. Cells were post-fixed in osmium 
tetraoxide for 30 min, and washed with distilled water and subsequently dehydrated using increasing ethanol 
concentrations (70%, 85%, 95% and 100%), for 10 min each, followed by immersion in propylene for 20 min, two 
times. Next, cells were infiltrated with a 1:1 mixture of propylene oxide and Spurr’s Resin for 1 hand then left in 
100% Spurr’s Resin overnight. They were then embedded in Beem Capsules using fresh Spurr’s Resin and left 
in an oven at 70 °C to polymerize. Excess resin was trimmed and 90 nm sections of cells were made on a Leica 
Ultracut Ultra microtome. Sections were placed on 200 mesh copper grids, stained with saturated uranylacetate in 
50% ethanol for 6 min, followed by rinsing in water and staining for 90 s in lead citrate. Grids were then washed in 
water, dried on filter paper and viewed under a FeiTecnai transmission electron microscope rated at 80 kV. Images 
were obtained using an AMT camera with AMT digital software.
Preparation of microvesicles for TEM. Microvesicles released from iPSCs were isolated from 50 ml 
of culture supernatant using differential centrifugation. Then 5 μ l of suspension containing isolated MVs was 
dropped on a Zoo-mesh Carbon Formuar grid; MVs were allowed to absorb for 20 min at room temperature. 
www.nature.com/scientificreports/
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Excess suspension was wicked off and grids were submerged in 25% gluturadeliyde/4% PFA with 25% tannic acid 
in PBS for 10 min. Grids were then washed in distilled water and viewed on a FeiTecnai transmission electron 
microscope, operated at 60kv. Digital images were obtained using an AMT digital camera and software.
Preparation of microvesicles for scanning electron microscopy (SEM). Microvesicles released from 
iPSCs were isolated from 50 ml of the culture supernatant using differential centrifugation. The isolated MVs 
sample was added to membrane filter discs and incubated in 3% glutaraldehyde (dissolved in PO4 buffer) for 1 h at 
room temperature. Glutaraldehyde was then aspirated, and the MVs sample was washed with PO4 buffer 4 times, 
at 10 min. intervals. To dry the sample, PO4 buffer was exchanged with ethanol. To avoid osmotic shock, ethanol 
concentration was gradually increased (10, 30, 50, 70, and 90%). The final step was performed in 100% ethanol 
for 1 h with three changes of ethanol. Samples were dried with liquid CO2 and sputtered with gold. Samples were 
imaged using a ZeissSupra55VP scanning electron microscope.
Total RNA purification. Total RNA from iPSCs and microvesicles was isolated using a Max-96 total RNA 
kit (Life Technologies). Briefly, 20 μ L of bead mix was added to iPSCs or MV pellets, and shaken for 5 min. Then, 
the RNA was magnetically captured by the RNA binding beads and washed with 150 μ L wash solutions 1 and 2, 
followed by shaking for 1 min per wash. 50 μ L of Diluted TURBO DNase was added to the sample followed with 
shaking for 10–15 min at room temperature. After adding 100 μ L of RNA rebinding solution, the sample was 
shaken for 3 min. 150 μ L of wash solution 2 was added twice to the sample, followed by shaking for 2 min. Next, 
50 μ L of elution buffer was added to the sample followed by vigorous shaking for 3 min. The supernatant was 
transferred to a nuclease-free container. Isolated RNA was measured for quality using a Nano drop ND/1000 
spectrophotometer and analyzed by 2% gel electrophoresis.
Real-time PCR analysis. Total RNA (500 ng) from MVs and iPSCs was reverse-transcribed to generate 
cDNA using AMV first strand cDNA synthesis kit (New England Biolabs). 10 ng of reverse-transcribed single 
strand cDNA was used as a template for real-time PCR in 50 μ L of RT-PCR mix. Forty cycles of PCR were per-
formed on cDNA samples using SYBR Green ER qPCR ER Supermix (Invitrogen) and six primers including: 
c-Myc, Klf4, Nanog, β -actin, GAPDH and Oct-3/4. The PCR reaction consisted of an initial enzyme activation 
step, at 95 °C for 10 min, followed by 40 cycles at 95 °C for 15 s and at 60 °C for 60 s, then followed by melting curve 
analysis. RT-PCR was carried out in triplicates for each pair of primer. Student’s t-test was used to identify sig-
nificant differences in mRNA, Ct values, between iPSCs and MVs and p values of less than 0.05 were considered 
statistically significant.
Immunoelectron microscopy. Five μ l of resuspended 2% paraformaldehyde fixed MVs were put on glow 
discharged formvar-carbon coated nickel grids. After washing with PBS, the grids were incubated with 50 mM gly-
cine/PBS for 3 min. The grids were blocked for 10 min with either 1% coldwater fish skin gelatin (Sigma-Aldrich) 
for the surface immunolabeling (Tsg101, Abcam), or 5% BSA, 5% goat serum, 0.1% cold-water fish skin gelatin 
and 0.1% saponin in PBS for inner membrane protein labeling (Nanog and Oct4, Abcam). Primary antibodies 
in blocking solution for Tsg101 or in antibody incubation buffer (0.1% BSA and 0.1% saponin) for Nanog and 
Oct4 were applied for 2 hours at room temperature. Controls were prepared in the absence of primary antibodies. 
After washing with PBS, Nanogold-labeled Fab’ anti-rabbit or anti-mouse (Nanoprobes, NY), or 5 nm, 10 nm 
gold conjugated goat anti-mouse antibodies (Ted Pella Inc. Redding, CA) were applied in the correlated anti-
body incubation buffer for 1 hour. The grids were then washing with PBS, fixed in 1% glutaraldehyde for 5 min. 
After thoroughly washed with distilled water, the grids were either directly go to methylcellulose embedding for 
5 nm or 10 nm gold, or continue with silver enhancement for nanogold. For the silver enhancement, the grids 
were washed with 0.02 M sodium citrate (pH 7.0), and performed silver enhancement in the dark using HQ 
Silver enhancement kit (Nanoprobes, NY) at room temperature for 8 min. After washing with distilled water, the 
grids were contrasted and embedded in a mixture of 3% uranyl acetate and 2% methylcellulose in a ratio of 1–9. 
Stained grids were examined under Philips CM-12 electron microscope and photographed with a Gatan (1k× 1k) 
digital camera. All antibodys were purchased from Abcam, USA. Anti-Tsg101 (1:200), Anti- Nanog (1:400) and 
Anti-Oct4 (1:200) were diluted according to manufacturer’s instruction.
Transfer and fusion of PKH26-labelled iPSC microvesicles to RPCs. Microvesicles from 
PKH26-labelled iPSCs, were isolated from 50 ml of culture supernatant using differential centrifugation. 
PKH26-labelled microvesicles were incubated with retinal progenitor cells (RPCs) in culture at 37 °C for 3 h. 
RPCs were used to demonstrate iPSC-MV binding within a robust neural progenitor population. RPCs with 
fused PKH26-labelled microvesicles were fixed in 4% PFA for 20 min and washed with PBS 3 times, 10 min each. 
Samples were imaged using a Leica SP2 AOBS confocal microscope with 40× oil immersion objective and digital 
zoom. A HeNe laser was used for PKH26-labelled MVs. The excitation wavelength was 543 nm and the emission 
range was 553–650 nm. A 488 Argon Laser was used to image for GFP RPCs.
Results
Size and Concentration of microvesicles derived from iPSCs. Microvesicles isolated from iPSCs 
were analyzed using nanoparticle tracking analysis technology (NTA). NTA tracking allowed a robust analysis of 
secreted vesicle size and release rate (Fig. 1). Data shows chat iPSC released MVs have diameters that fall within 
the range reported for secreted microparticles (100 nm–1 um)8,10. MVs derived from iPSC conditioned media at 
three time points, 12, 24 and 48 h showed stable mean diameters of 122 ± 2.3 nm, 124 ± 6.0 nm and 122 ± 2.2 nm, 
respectively. The concentration of released MVs was calculated using a Student’s t-test and the average number of 
MVs in conditioned medium at 12 h = (1.69 ± 0.66)* 108, 24 h = (3.80 ± 0.77)* 108 and 48 h = (4.20 ± 0.40)* 108 
(Fig. 1F). The number of MVs released per cell/hr was also calculated after data was normalized to control media. 
www.nature.com/scientificreports/
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At 12 h post-plating of 1 × 106cells, individual iPSCs had released an estimated 2200 ± 884 MVs; at 24 h the num-
ber increased to 5000 ± 1023 MVs and at 48 h 5300 ± 220 MVs were released (data not shown). A sample of a 
20 s Nanosight video, from which the 12 h time point MV brownian movement and tracking data were derived, is 
provided in supplemental movie 1 (S1).
TEM analysis revealed release of MVs from iPSCs (Fig. 2A). TEM shows a microparticle (> 100 nm) budding 
from the plasma membrane into the extracellular space (Fig. 2A, arrowhead). To further confirm lipid involve-
ment in release of MVs from iPSCs, we utilized confocal analysis of PKH26 labeled cell membrane and imaged 
the release of MVs emerging from iPSCs (Fig. 2B–D). Our analysis suggests that both exosomes and micropar-
ticles were released from PKH26-lablelled iPSCs. Exosome budding appeared across the plasma membrane with 
release occurring periodically in cluster sites.
Morphology of microvesicles isolated from iPSCs. The morphology and size of isolated iPSC microve-
sicles were analyzed using SEM and TEM. Visualization of iPSC MVs isolated via ultra centrufugation and imaged 
using SEM revealed heterogeneous spheroid morphologies with sizes ranging from 30 to 300 nm. SEM shows 
microparticles (Fig. 3A) to be approximately 100–300 nM, while exosomes ranged from 30–95 nm (Fig. 3B). The 
smooth shape of the MV surface, observed on the SEM image, can be attributed to the physical properties of the 
phospholipid bilayer. Using TEM analysis Fig. 3D shows a sample of an isolated microparticle with a diameters of 
approximately 130 nM. A second image shows an exosome with the characteristic spheroid shape and a diameter 
of approximately 70 nM (Fig. 3C). TEM images revealed that iPSC exosomes have a cup-shaped appearance, 
which uniquely differentiates them from microparticles. Microparticles appeared consistently spheroid in shape. 
This level of TEM analysis aligns with previous studies describing microparticles as heterogeneous in shape and 
larger than exosomes with diameters reaching up to 1 μ m27,28.
RNA and protein identified in microvesicles derived from iPSCs. The total RNA profile of iPSC MVs 
was determined by native agarose gel electrophoresis. As displayed in Fig. 4A, the 18 S and 28 S ribosomal RNA 
bands are clearly visible in the total RNA profile of iPSCs (lane2); in contrast, the total RNA from iPSC derived 
MVs does not contain 28 S and 18 S ribosomal RNA (lane1). The largest fraction of total RNA isolated from the 
MV population appeared as a lower molecular weight band suggesting the presence of mRNA and small RNA 
species. We then confirmed the presence of selected mRNA species in iPSC MVs. Isolated total RNA from iPSC 
MVs (1 μ g) was reverse-transcribed and used as a template for amplification using the primers shown in Table 1. 
Figure 1. iPSC microvesicle diameter and release rate. (A–C) MV nanometer diameter range and 
concentration were derived from iPSC conditioned media at 12 h, 24 h and 48 h, respectively. MV diameters 
and concentrations for three samples at each time point are indicated in colored traces. Mean diameters 
and standard deviation for each time point remained consistent; 12 h 122 ± 2.3 nm, 24 h 124 ± 6.0 nm, 48 h 
122 ± 2.2 nm. (D) Arrows show light-scattering of individual MVs from a single frame of Nanosight tracking 
analysis at 24 h. (E) 3D plot showing MV size/relative intensity. (F) Average number of MVs in conditioned 
media at 12 h = (1.69 ± 0.66)* 108, 24 h = (3.80 ± 0.77)* 108 and 48 h = (4.20 ± 0.40)* 108. Error bars represent 
standard deviation. Student’s t-test was performed to analyze iPSC release rates. p < 0.05 was considered 
statistically significant. “ns” represents not significantly different.
www.nature.com/scientificreports/
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The house keeping genes β -actin and GAPDH were tested as positive controls and were present in both iPSCs 
and MVs (Fig. 4B). Both β -actin and GAPDH displayed significantly lower expression level in MVs than in iPSCs 
(p < 0.05). Due to baseline differences in expression levels, β -actin and GAPDH were not normalized to in our 
experiments. To compare expression levels of transcription factors between iPSCs and MVs, the same amounts of 
RNA were used in reverse-transcription. Four transcription factors including Oct-3/4, Nanog, Klf4, and C-Myc 
were found in both cells and isolated MVs, but expression levels were lower in MVs than in iPSCs (Fig. 4B). With 
the exception of Klf, each RNA species analyzed was present in higher levels in cells than MVs. The rRNA content 
was also compared between MVs and iPSCs of origin, showing MVs lack 18 S and 28 S rRNA species (Fig. 4A).
The protein content of iPSC MVs was visualized using immunogold TEM. In Fig. 5, black punctate regions 
indicate immunogold labeling of the homeodomain transcription factor Nanog, the homeodomain transcription 
factor Oct-3/4 and the the tetraspanprotein TSG101 protein within MVs. Each pluripotent protein identified 
within MVs has established roles in maintaining undifferentiated iPSC self-renewal.
Fusion of microvesicles derived from iPSCs with RPCs in vitro. The red fluorescent lipophilic mem-
brane dye PKH26 was used to label isolated iPSC derived MVs, which were then incubated with target RPCs to 
evaluate MV docking and fusion (Fig. 6). Following three hours of co-incubation, IPSC derived MVs attached 
to RPCs and a percentage remained adherent flowing multiple rinses with warmed media. Imaging revealed the 
binding of single and clustered MVs across the surface of GFP RPCs with varying morphologies, as single cells 
and within larger colonies. MV binding appeared to be facilitated via lipid fusion as MVs were visible only on cells 
and not on cell-free culture surfaces following rinsing. A sample z-stack 3D confocal reconstruction of MV fusion 
to GFP RPCs is available in supplemental movie 2 (S2).
Discussion
In this study we observed that iPSC MV generation and release are consistent with previous studies describing 
components of microvesicle biogenesis14,29. We discovered that the cargo of iPSC derived MVs incudes mRNA 
and protein species involved in self-renewal and pluripotentcy30–32. In addition, SEM and TEM analysis of iPSC 
Figure 2. Analysis of cell surface microvesicle formation. (A) TEM image of exosome formation at the iPSC 
surface (Fig. 2A, arrowhead), scale: 500 nm. (B) Bright field image of iPSC with surface topology suggestive of 
vesicle formation at the cell membrane, (C) Following PKH26 (red) lipophilic labeling, emerging vesicles at 
the iPSC lipid bilayer appear concentrated near the soma with observable variations in size, (d) DAPI nuclear 
labeling with overlay of (B,C), scale: 10 μ m.
www.nature.com/scientificreports/
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Figure 3. SEM and TEM analysis of iPSC derived microvesicles. SEM analysis of MV populations isolated 
from iPSCs revealed a heterogenous population of spheroid vesicles ranging in size from 30–300 nm. (A) SEM 
of an MV population with a sample microparticle measured with a diameter of 103 nM, scale bar: 200 nm.  
(B) A higher magnification SEM image showing measured exosomes with diameters of 73.60 and 93.42 nm.  
(C) TEM analysis of MVs isolated from iPSC supernatant showed characteristic cup-shaped morphology and 
size (arrowhead) and (D) spheroid exosome (arrowhead) scale bar: 100 nm.
Figure 4. iPSC microvesicles contain pluripotent transcription factor mRNA. (A) Total RNA isolated 
from iPSC derived MVs lacks 28 S and 18 S rRNA as revealed through 2% denaturing agarose gel loaded with 
total RNA from iPSC MVs and iPSCs. (B) To verify the presence of selected iPSC derived mRNA, MV mRNA 
was analyzed using real-time PCR and contained factors involved in the maintenance of iPSC pluripotency 
including Oct-3/4, Nanog, Klf4, and C-Myc, Positive controls β - actin and GAPDH were present in iPSCs 
and MVs. Significant differences between cells and MVs are denoted with asterisks: *(p < 0.05), **(p < 0.01), 
***(p < 0.001), ****(p < 0.0001); “ns” - not significantly different.
www.nature.com/scientificreports/
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derived MVs was consistent with previous findings, describing microparticles as heterogeneous in shape, and 
exosomes with cup-shaped morphologies22,33.
In the process of electron microscopic analysis, we observed nano sized, grain-like structures (> 20 nm) in 





























Table 1. Primers used for real-time PCR.
Figure 5. Immunogold EM analysis of Microvesicle Protein Content. Immunogold EM images reveal the 
presence of (A) the homeodomain transcription factor Nanog, (B) the homeodomain transcription factor 
Oct-3/4, (C) the tetraspanprotein Tsg101, a canonical MV marker, and (D) control. Each pluripotent protein 
identified within MVs is involved in undifferentiated iPSC self-renewal. Samples were viewed under a FeiTecnai 
Transmission Electron Microscope. Scale: 50 nm.
www.nature.com/scientificreports/
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during sample preparation for SEM. Additional studies may advance MV analysis by use of flow cytometry. An 
advantage of flow cytometry is that no sputtering procedures are needed. A disadvantage would be that the struc-
tural features of the MVs would remain indistinct34 and most systems cannot reliably acquire data on the smaller 
size MVs (> 500 nm). To address these current technical challenges in the field of MV analysis, the Scientific 
Standardization Committee of the International Society on Thrombosis and Haemostasis are evaluating stand-
ardized protocols for both MV isolation and analysis9.
Our findings support existing data describing the process of microparticle and exosome genesis. However, the 
signaling mechanisms of initiation and termination of MV genesis remains to be fully elucidated10. Using TEM, 
we showed how microparticles were formed by the process of lipid bilayer budding14. We also observed exosome 
secretion from multivesicular bodies (data not shown). Among membranous vesicles, exosomes are the only type 
that originate from intracellular compartments, such as the MVBs33. According to a previous study, MVBs either 
fuse with lysosomes to degrade their bioactive load or fuse with the plasma membrane to release their exosomes 
into the extracellular environment11.
In agreement with a number of studies, our findings support that MVs contain a subset of mRNA and protein 
derived from the cell type of origin3,8,20. In particular, we have shown that iPSC MVs contain mRNA and protein, 
which encode for and function as transcription factors critical to maintaining iPSC pluripotency. In addition, 
iPSC MVs are enriched in the transcription factors Nanog and Oct-3/4, important for iPSC self-renewal. Current 
understanding of cell targeting of subsets of RNA and proteins to MVs remains limited35. A recent study suggest 
that ES MVs transfer a specific subset of miRNAs and mRNA in a highly selective manner possibly regulated by 
proteins found MV mebranes8. Cargo selection for MVs may also be understood by comparing the expression 
profile of mRNA and miRNA in the cells of origin and the presence of ribonucleo proteins that function in the 
intracellular transport13. For example, MVs released from MSCs have been shown to contain both cell specific 
mRNA and ribonucleo proteins that function in RNA storage, transport and stability. Current studies suggest that 
MV cargo uptake is facilitated by clathrin-mediated processes with ribonucleo proteins targeting miRNA and 
mRNA and N-linked glycosylation directing protein cargo13,36,37.
In this work, our confocal analysis confirms earlier studies showing that an essential mechanism through 
which MVs communicate with target cells is by fusing directly with the plasma membrane (Fig. 6). Here FITC 
labeled MVs remained bound to, and potentially became internalized in, RPCs following a brief incubation. Our 
3D confocal reconstruction of MV fusion inS2 shows robust fusion at several points on target RPCs. MVs have 
been reported to release their contents into the cytoplasm of target cells with the potential of influencing gene 
Figure 6. iPSC microvesicles fuse to target cells in vitro. (A) iPSC MV co-cultured GFP+ RPCs remain viable 
expressing GFP ubiquitously throughout the cytoplasm and robust branching morphology. (B) Dendritic 
processes and cell-to cell contacts visible using phase contrast. (C) MVs isolated from iPSCs labeled with the red 
fluorescent lipophilic dye PKH26fuse to GFP+ RPCs. (D) Overlay (A–C). scale 10 μ m.
www.nature.com/scientificreports/
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expression states, viability and plasticity15,19. Recent findings indicate that fusion is the initial step required for 
horizontal transfer of MV genetic cargo as well as proteins, phospholipids and organelles38,39.
Further analysis of the process of iPSC MV transfer of pluripotent transcripts and protein will build on data 
presented here. MVs derived from ES and iPSCs may influence expression patterns toward pluripotentcy in target 
cells2. Recently it has been shown that ES MVs can alter the gene expression of retinal Muller cells contributing 
to trans differentiation, an initial step toward regeneration40. The finding that ES MVs may switch on early pro-
grams of pluripotency suggests that MVs may serve as therapeutic agents to restore the regenerative potential of 
the retina. In line with this research, iPSCs may be developed as a patient specific vehicle for delivery of genetic 
cargo toward nervous system repair. In support of the in vivo neuro protective potential of MVs in retinal disease, 
a recent study has examined the role of exosome transfer of crystallin (a biomarker in age related macular degen-
eration) between retinal pigment epithelial cells and photoreceptors. The authors demonstrated that MV-secreted 
crystalline was neuro protective for photoreceptors41. Additional studies suggest that miRNAs may be potential 
therapeutic targets for age related macular degeneration42. Since it may be harmful to inject naked siRNAs into 
the eye, MVs may also be useful to transfer miRNA to treat retinal disease8.
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